Expanding the clinical and genetic spectrum of G6PD deficiency: the occurrence of BCGitis and novel missense mutation

Khan, Taj Ali; Mazhar, Humaira; Nawaz, Mehboob; Kalsoom, Kalsoom; Ishfaq, Muhammad; Asif, Huma Iqbal; Rahman, Hazir; Qasim, Muhammad; Naz, Farkhanda; Hussain, Mubashir; Khattak, Baharullah; Ullah, Waheed; Cabral-Marques, Otavio; Butt, Jawad; Iqbal, Asif.
Microb. Pathog. ; 102: 160-165, 2017.
Artículo en Inglés | SES-SP, SESSP-IBPROD, SES-SP | ID: but-ib13611

Documentos relacionados

  1. Expanding the clinical and genetic spectrum of G6PD deficiency: The occurrence of BCGitis and novel missense mutation.
  2. Stabilization of glucose-6-phosphate dehydrogenase oligomers enhances catalytic activity and stability of clinical variants.
  3. Glucose-6-Phosphate Dehydrogenase: Update and Analysis of New Mutations around the World.
  4. Glucose-6-Phosphate Dehydrogenases: The Hidden Players of Plant Physiology.
  5. Allosteric role of a structural NADP<sup>+</sup> molecule in glucose-6-phosphate dehydrogenase activity.
  6. A computational study of structural differences of binding of NADP<sup>+</sup> and G6P substrates to G6PD Mediterranean<sup>c.563T</sup>, G6PD A-<sup>c.202A/c.376G</sup>, G6PD Cairo<sup>c.404C</sup> and G6PD Gaza<sup>c.536A</sup> mutations.
  7. Nitric oxide and hydrogen sulfide modulate the NADPH-generating enzymatic system in higher plants.
  8. Severe glucose-6-phosphate dehydrogenase deficiency leads to susceptibility to infection and absent NETosis.
  9. [LCAT deficiency: a nephrological diagnosis].
  10. Inhibition of glutathione reductase uncovers the activation of NADPH-inhibited glucose-6-phosphate dehydrogenase.